Manufacturers should exhibit that any new technology or method not simply satisfies the prevailing criteria for sterility assurance but also offers tangible Advantages concerning effectiveness, reliability, or products protection. As these new technologies emerge, the WHO emphasizes the necessity of a radical danger evaluation and validation process. From the waiting for link from Forum Profiles (11)